Core Scientific (CORZ) is trading higher as the market focuses on incremental financing momentum for its AI/HPC data center pivot. The key catalyst is the company’s expanded delayed-draw bridge credit agreement, which increased total term-loan commitments to $1.0 billion by adding a $500 million incremental commitment, and the company drew the full additional $500 million on March 18, 2026.

For CORZ, access to a larger, bank-led facility increases perceived execution confidence on near-term site conversions, equipment procurement, and data center infrastructure spending tied to hosting high-density compute workloads. The financing headline also reinforces the broader narrative that capital markets are willing to fund the company’s shift away from bitcoin mining and toward contracted AI infrastructure economics.

Investors will be monitoring how quickly the new funds translate into deliverable capacity, customer diversification beyond its largest hyperscale relationship, and the company’s ability to manage higher debt and interest expense as buildouts ramp. Any follow-on updates—such as additional customer wins, revised capacity timelines, or further amendments to lending terms—could drive the next leg of volatility.